These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8230059)

  • 1. Proteinase inhibitors in malignancy: therapeutic promise or another white elephant?
    Dodwell DJ
    J R Soc Med; 1993 Oct; 86(10):573-6. PubMed ID: 8230059
    [No Abstract]   [Full Text] [Related]  

  • 2. Batimastat. BB 94, collagenase inhibitors-1.
    Drugs R D; 1999 Feb; 1(2):139-41. PubMed ID: 10566008
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting Proteases in Cystic Fibrosis Lung Disease. Paradigms, Progress, and Potential.
    McKelvey MC; Weldon S; McAuley DF; Mall MA; Taggart CC
    Am J Respir Crit Care Med; 2020 Jan; 201(2):141-147. PubMed ID: 31626562
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proteases and protease inhibitors in the treatment of cancer].
    Brünner NA
    Ugeskr Laeger; 1999 Mar; 161(11):1577-80. PubMed ID: 10202439
    [No Abstract]   [Full Text] [Related]  

  • 5. Intramembrane proteolysis.
    Wolfe MS
    Chem Rev; 2009 Apr; 109(4):1599-612. PubMed ID: 19226105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proteases, their inhibitors and lung diseases].
    Liu CE; Wang JL
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):237-40. PubMed ID: 2700081
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases.
    Johnson LL; Dyer R; Hupe DJ
    Curr Opin Chem Biol; 1998 Aug; 2(4):466-71. PubMed ID: 9736919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.
    Robinson LA; Wilson DM; Delaet NG; Bradley EK; Dankwardt SM; Campbell JA; Martin RL; Van Wart HE; Walker KA; Sullivan RW
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2381-4. PubMed ID: 12824039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of protease and protease inhibitors in cancer pathogenesis and treatment.
    Eatemadi A; Aiyelabegan HT; Negahdari B; Mazlomi MA; Daraee H; Daraee N; Eatemadi R; Sadroddiny E
    Biomed Pharmacother; 2017 Feb; 86():221-231. PubMed ID: 28006747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
    Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
    Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and function of intracellular proteinases and proteinase inhibitors from yeast.
    Holzer H
    Acta Biol Med Ger; 1977; 36(11-12):1523-4. PubMed ID: 358707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase inhibition in invasive cancer therapy: four control levels of matrix degradation.
    Opdenakker G; Paemen L; Norga K; Masure S
    Int J Cancer; 1997 Mar; 70(5):628-30. PubMed ID: 9052766
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical and clinical studies of MMP inhibitors in cancer.
    Drummond AH; Beckett P; Brown PD; Bone EA; Davidson AH; Galloway WA; Gearing AJ; Huxley P; Laber D; McCourt M; Whittaker M; Wood LM; Wright A
    Ann N Y Acad Sci; 1999 Jun; 878():228-35. PubMed ID: 10415734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitors of pancreatic proteolytic enzymes].
    Loginov AS; Amirov NSh; Chernoiarova OD
    Vestn Akad Med Nauk SSSR; 1989; (1):53-61. PubMed ID: 2652912
    [No Abstract]   [Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibitors.
    Ramnath N; Creaven PJ
    Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
    Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
    Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteolytic enzymes and their inhibitors in clinical and experimental oncology].
    Geshelin SA; Vovchuk SV; Blizniuk BF; Varbanets VF
    Vopr Onkol; 1984; 30(10):9-18. PubMed ID: 6208687
    [No Abstract]   [Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?
    Rudek MA; Venitz J; Figg WD
    Pharmacotherapy; 2002 Jun; 22(6):705-20. PubMed ID: 12066962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acid stable proteinase inhibitors of the respiratory tract. Chemistry and function.
    Hochstrasser K
    Bull Eur Physiopathol Respir; 1980; 16 Suppl():223-30. PubMed ID: 7013875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.